Biomet Restates Earnings

Biomet restated its earnings for the past four years in a report to the Securities Exchange Commission yesterday. The restatement shows net income for the Warsaw orthopedics company to be as much as seven-point-four million dollars lower than originally reported. An investigation into stock option irregularities led to the restatement.